Expanding medical abortion in Tunisia:: women's experiences from a multi-site expansion study
Expanding medical abortion in Tunisia:: women's experiences from a multi-site expansion study
复制标题
DOI：
10.1016/j.contraception.2004.06.012
复制
发表时间：
2004-12-01
期刊：
影响因子：
2.9
通讯作者：
Winikoff, B
中科院分区：
文献类型：
--
作者：
Hajri, S;Blum, J;Winikoff, B
从2000年11月至2001年7月，在全国四个地点登记了321名同意堕胎的妇女，以证明突尼斯各地的提供者可以安全地使用米非司酮药物堕胎。符合研究纳入标准的妇女口服200毫克米非司酮，并可在2天后在家或诊所选择口服400马克米索前列醇。在随访中，对妇女进行了检查，以确定完成堕胎的情况，并调查了她们对该方法的满意度。96%的妇女使用这种方法成功堕胎。妇女表示强烈倾向于在家使用米索前列醇，这表明它更保密（34%），更容易（28%），需要更少的诊所就诊（28%）。该方法在新设施和新提供者中的高成功率、已证明的安全性和可接受性表明，通过合理水平的培训和监督，可以安全地扩展到新的环境中。(C) 2004爱思唯尔公司版权所有。
From November 2000 to July 2001, 321 consenting women were enrolled at four sites across the country in an effort to demonstrate that mifepristone medical abortion could safely be used by providers throughout Tunisia. Women who met the study's inclusion criteria were given 200 mg oral mifepristone and offered the choice of taking 400 mug oral misoprostol 2 days later either at home or at the clinic. At follow-up, women were examined to determine completed abortion status and surveyed to gauge their satisfaction with the method. Ninety-six percent of women had a successful abortion using this method. Women expressed a strong preference for home use of misoprostol, indicating that it is more confidential (34%), easier (28%) and requires fewer clinic visits (28%). The high rate of success, demonstrated safety and acceptability of the method in new facilities and with new providers suggests that medical abortion can be safely expanded to new settings with reasonable levels of training and supervision. (C) 2004 Elsevier Inc. All rights reserved.